pRESET for Occlusive Stroke Treatment

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 340 participants.

Also called NCT03994822

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 340 participants (enrolled count) (from the registry)
Sponsor
phenox Inc. (from the registry)
Registry
  • NCT NCT03994822
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United States, Germany (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03994822. Randomized; single masking; primary purpose treatment. Start 2019-10-04 (actual); primary completion 2022-05-12 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
pRESET for Occlusive Stroke Treatment
Acronym
PROST
Condition
Brain Diseases
Condition
Cardiovascular Diseases
Condition
Central Nervous System Diseases
Condition
Cerebrovascular Disorders
Condition
Ischemia
Condition
Nervous System Diseases
Condition
Pathologic Processes
Condition
Stroke, Ischemic
Condition
Stroke, Acute
Condition
Vascular Diseases
Intervention (Device)
Mechanical Thrombectomy using the pRESET Thrombectomy device
Intervention (Device)
Mechanical Thrombectomy using the Solitaire Revascularization Device
Lead sponsor
phenox Inc. (class: industry)

Record details

Record id
cardio:ct-nct03994822
Content hash
4b092047b83a5b8e089236c4d3724d78930cb49420f5948f2f09cb1f649ad9e0